Vardaan Biotech IPO
Vardaan Biotech IPO — date, issue size, SEBI status & DRHP details 2026
Vardaan Biotech filed its draft red herring prospectus (DRHP) with SEBI on 22 Sep 2026 for an IPO of a fresh issue of up to 3,50,00,000 shares. SEBI has sought clarifications and is waiting for the lead manager's reply. The price band, lot size and IPO dates are not announced yet.
Vardaan Biotech is an integrated seed company from Ujjain that sells hybrid and improved seeds of cereals, vegetables, pulses and oilseeds in 9 states. Revenue from operations grew from Rs 140.14 crore in FY2024 to Rs 167.09 crore in FY2026.
Where the Vardaan Biotech IPO stands
From draft to listing. Today is 11 November 2026.
- DRHP filed 22 Sep 2026
- SEBI observations TBA
- RHP & price band TBA
- Bidding TBA
- Listing TBA
| DRHP filed with SEBI | 22 Sep 2026 |
|---|---|
| SEBI status | SEBI queries pending · 6 Nov 2026 |
| Last SEBI communication | 6 Nov 2026 |
| Coordinating lead manager | Interactive Financial Services Limited |
| RHP, price band & dates | Not announced |
Vardaan Biotech IPO details
The offer as the DRHP describes it. Terms can change in the RHP.
| Issue type | Fresh issue only |
|---|---|
| Fresh issue | Up to 3,50,00,000 shares |
| Offer for sale | None |
| Total issue size | Depends on the price band |
| Face value | ₹2 per share |
| Proposed listing | BSE, NSE |
| Price band | Not announced (comes with the RHP) |
| Lot size | Not announced |
| IPO dates | Not announced |
| Book running lead managers | Interactive Financial Services Limited, Jajodia Equity Advisors Services Limited |
| Registrar | Bigshare Services Private Limited |
Strengths & risks
The case for and against, from the DRHP's own numbers and risk factors.
Strengths · 7
- 01Revenue from operations rose from Rs 140.14 crore in FY2024 to Rs 151.13 crore in FY2025 and Rs 167.09 crore in FY2026.
- 02Profit after tax rose from Rs 16.48 crore in FY2024 to Rs 18.35 crore in FY2026, and EBITDA margin stayed between 17.03% and 17.86% over the three years.
- 03Borrowings fell from Rs 30.24 crore in FY2024 to Rs 18.86 crore in FY2026, and debt to equity came down from 0.70 to 0.19.
- 04Direct sales to farmers grew from Rs 72.87 crore in FY2024 to Rs 108.61 crore in FY2026, so the company is less dependent on dealers.
- 05The product range spans cereals, vegetables, herbs, pulses, oilseeds and fodder, sold across 9 states in both Kharif and Rabi seasons.
- 06Net worth grew from Rs 43.37 crore in FY2024 to Rs 99.55 crore in FY2026, and the current ratio improved from 2.50 to 2.90.
- 07Own processing capacity is 1,15,50,000 kg a year at Ujjain, backed by two third-party processing units in Hyderabad.
Risks · 10
- 01Promoter Lokendra Singh Rajput faces a criminal proceeding and investigations by law enforcement agencies, including the Economic Offences Wing. The document lists 1 criminal case against the promoters.
- 02Operating cash flow was negative at Rs -6.08 crore in FY2026 and Rs -11.95 crore in FY2024, even though profit after tax was positive in both years.
- 03Working capital days were 237 in FY2026, up from 180 in FY2024, so a large amount of money is tied up in inventory and receivables.
- 04The statutory auditor, Maheshwari & Co., gave an adverse remark because the audit trail feature in the accounting software was not enabled.
- 05Revenue depends on certain products, mainly maize, paddy and wheat seeds, and on two states, Madhya Pradesh and Maharashtra.
- 06Procurement is concentrated in Telangana, Madhya Pradesh and Gujarat, so a problem in these states can disrupt supply.
- 07Return on net worth fell from 38.00% in FY2024 to 18.43% in FY2026, and EBITDA margin was 17.03% in FY2026 against 17.86% in FY2025.
- 08There are 23 criminal proceedings against the company with Rs 144.21 lakh involved, plus 4 tax proceedings. The company has also filed 23 criminal proceedings with Rs 95.21 lakh involved.
- 09The issue is a fresh issue, but the money is partly for general corporate purposes and a land purchase and office purchase, and the amounts are still blank in the draft.
- 10Seed output depends on weather, crop disease and pests, and on the success of the company's own breeding work.
Vardaan Biotech financials
Restated figures in ₹ crore, as reported in the DRHP.
| ₹ crore | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 167.09 | 151.13 | 140.14 |
| EBITDA | 28.46 | 26.99 | 24.09 |
| Profit After Tax | 18.35 | 17.61 | 16.48 |
| Net Worth | 99.55 | 61.00 | 43.37 |
| Total Borrowing | 18.86 | 29.59 | 30.24 |
Key ratios (FY26)
P/E and market capitalisation need the price band and are added when the RHP is out.
Where the IPO money goes
How Vardaan Biotech plans to use the fresh issue proceeds.
About Vardaan Biotech
The company follows an integrated model. It collects germplasm, breeds and develops hybrids, gets seed grown through contract production, then procures, stores, processes, tests, packs and markets the seed. It also gives farmers advice. Its range covers cereals (paddy, wheat, maize, bajra), vegetable seeds (peas, tomato, chilli, okra, onion and others), herb seeds (coriander, mint, fennel, tulsi), pulses (pigeon pea and green pea), oilseeds (mustard, soybean, sunflower) and fodder seeds (fodder bajra and fodder jowar).
The seeds are sold through distributors, dealers and direct farmer connections in 9 states: Madhya Pradesh, Maharashtra, Telangana, Bihar, Jharkhand, Rajasthan, Gujarat, Chhattisgarh and Uttar Pradesh. In FY2026, sales to farmers were Rs 108.61 crore and sales through dealers were Rs 58.48 crore. In FY2024 the split was Rs 72.87 crore from farmers and Rs 67.27 crore from dealers.
The company has one processing unit on leased land at Gram Jaithal, Agra Road, Ujjain. Its installed capacity is 1,15,50,000 kg a year, as certified by a chartered engineer on 8 July 2026. It also has long-term arrangements with two third-party processors, each with a unit at Hyderabad, Telangana, which it uses when needed. The company says it does not report business segments under Ind-AS 108.
The promoters are Lokendra Singh Rajput, Chairperson and Whole-time Director, and Rashmi Rajput, Managing Director. Both have been with the company since it was incorporated in 2007. The company split its shares from face value Rs 10 to Rs 2 each from 6 August 2026.
The industry
The industry report by D&B says agriculture supports about 26% of global employment, according to the World Bank and ILO. The FAO figures cited show global agriculture value added rising from USD 3.1 trillion in 2014 to USD 4.0 trillion in 2023, an average annual growth of about 2.8%. The abridged prospectus quotes only these global numbers and does not give a size for the Indian seed market.
Customer concentration: The document does not report top-customer concentration. In FY2026, farmers gave Rs 108.61 crore and dealers gave Rs 58.48 crore of revenue.
Promoters & management
Before the issue, promoter Rashmi Rajput holds 42.77% and Lokendra Singh Rajput holds 14.26%. Promoter group members Samar Pratap Singh Rajput and Tanushka Singh hold 7.46% each.
| Name | Role |
|---|---|
| Lokendra Singh Rajput | Chairperson and Whole-time Director |
| Rashmi Rajput | Managing Director |
| Himanshu Singh | Chief Financial Officer |
| Shivani Maharshi Joshi | Company Secretary and Compliance Officer |
The bankers & the filings
Who is running the issue, and the SEBI documents this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Interactive Financial Services Ltd.
7 issues handled (3 mainboard, 4 SME)Best listing: SRM Contractors (+2.5%). Weakest: Shree Ram Twistex (-34.6%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Vardaan Biotech IPO: frequently asked
When will the Vardaan Biotech IPO open?
The Vardaan Biotech IPO dates are not announced yet. SEBI has sought clarifications and is waiting for the lead manager's reply. The company announces the dates and price band after it files its red herring prospectus (RHP) with the Registrar of Companies, usually a week or two before bidding opens. This page switches to the full IPO page with dates, price band and lot size as soon as that happens.
What is the Vardaan Biotech IPO price band?
The price band is not announced yet. It is set by the company and its lead managers and published with the RHP, a few days before the issue opens. The DRHP fixes only the face value of ₹2 per share.
How big is the Vardaan Biotech IPO?
Vardaan Biotech filed its draft red herring prospectus (DRHP) with SEBI on 22 Sep 2026 for an IPO of a fresh issue of up to 3,50,00,000 shares. The final size in rupees depends on the price band.
Has SEBI approved the Vardaan Biotech IPO?
SEBI has sought clarifications and is waiting for the lead manager's reply. SEBI observations are valid for 12 months; the IPO has to open within that window or the company must file again.
What is the Vardaan Biotech IPO GMP?
There is no grey market premium to report before the price band is announced. IPO Guru starts tracking the Vardaan Biotech IPO GMP once the RHP and price band are out.
What will Vardaan Biotech do with the IPO money?
As per the DRHP: Capital expenditure for expansion of the processing unit; Capital expenditure to buy land outright for seed breeding; Purchase of office premises at Vadodara, Gujarat; Working capital requirements of the company.
Who are the lead managers of the Vardaan Biotech IPO?
The book running lead managers are Interactive Financial Services Limited, Jajodia Equity Advisors Services Limited. Bigshare Services Private Limited is the registrar.
Is Vardaan Biotech profitable?
Yes. Profit after tax was Rs 18.35 crore in FY2026, Rs 17.61 crore in FY2025 and Rs 16.48 crore in FY2024. Operating cash flow was negative at Rs -6.08 crore in FY2026.
Who owns Vardaan Biotech?
The promoters, Rashmi Rajput and Lokendra Singh Rajput, hold 42.77% and 14.26% before the issue. Faithful Vincom Private Limited holds 8.92%.
What does Vardaan Biotech sell?
It sells hybrid and improved seeds of cereals, vegetables, herbs, pulses, oilseeds and fodder in 9 states, through dealers, distributors and direct farmer sales.
Other companies in the IPO pipeline
Mainboard companies with drafts filed with SEBI, same bankers first.
Know the day the price band is out.
We track every mainboard draft from SEBI filing to listing. When Vardaan Biotech files its RHP, this page becomes the full IPO page with dates, price band, lot size, GMP and subscription.
Not investment advice. Figures are from the company's draft offer document filed with SEBI and may change in the RHP.